Update on neurological paraneoplastic syndromes

Current Opinion in Oncology
Romana HöftbergerJosep Dalmau

Abstract

To provide an update on paraneoplastic neurologic syndromes (PNS), the involved tumors, and types of immune responses. PNS are a diverse group of syndromes that may present as a relatively isolated syndrome such as predominant cerebellar degeneration or limbic encephalitis, or with more complex phenotypes such as diffuse encephalomyelitis that affects different levels of the neuraxis producing a variety of clinical manifestations. The detection of specific antineuronal antibodies can confirm or strongly support the paraneoplastic cause of the syndrome and direct the search for the associated cancer. Previously thought to be unresponsive to therapy, it has recently been shown that there are some antibody-associated PNS that are highly responsive to treatment, including tumor-directed therapies and immunotherapy. The recognition of PNS is important for the early detection of an underlying malignancy and prompt initiation of therapies, which offers the best opportunity to stabilize or improve the neurological deficits and for those syndromes associated with cell surface antibodies usually results in substantial improvement or full recovery.

References

May 17, 2001·Brain : a Journal of Neurology·F GrausJ Y Delattre
May 6, 2003·Annals of Neurology·Sean J PittockVanda A Lennon
Feb 11, 2004·Neuro-oncology·Steven VerninoDavid W Kimmel
Jun 25, 2004·Brain : a Journal of Neurology·Josep DalmauMyrna R Rosenfeld
Jul 20, 2004·Journal of Neurology, Neurosurgery, and Psychiatry·F GrausR Voltz
May 21, 2005·Journal of Neuroimmunology·Paul W WirtzJan J G M Verschuuren
Jun 28, 2006·Journal of Neurology, Neurosurgery, and Psychiatry·L SabaterF Graus
Jul 13, 2006·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·C A VedelerUNKNOWN Paraneoplastic Neurological Syndrome Euronetwork
Mar 19, 2009·Cancer Immunology, Immunotherapy : CII·Sissel Evy MonstadChristian A Vedeler
Apr 2, 2009·Annals of Neurology·Meizan LaiJosep Dalmau
Jul 25, 2009·Journal of Neurology·K BürkR Voltz
Dec 26, 2009·Journal of Neurology·Francesc GrausJosep Dalmau
Mar 10, 2010·Archives of Neurology·Bruno GiomettoUNKNOWN PNS Euronetwork
Oct 1, 2010·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·M J TitulaerUNKNOWN European Federation of Neurological Societies
Mar 10, 2011·Annals of Neurology·Eric LancasterJosep Dalmau
Jun 20, 2012·Nature Reviews. Neurology·Eric Lancaster, Josep Dalmau
Nov 21, 2012·The Journal of Pediatrics·Thaís ArmangueUNKNOWN Spanish Anti-N-methyl-D-Aspartate Receptor (NMDAR) Encephalitis Work Group
Jan 1, 2013·Journal of Neuroimmunology·Romana HöftbergerFrancesc Graus
Dec 10, 2013·Annals of Neurology·Thaís ArmangueJosep Dalmau
Jan 23, 2014·Neuropathology and Applied Neurobiology·Romana HöftbergerFrancesc Graus
Jan 30, 2014·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·F DucrayJ Honnorat
Jul 23, 2014·Archives of Physical Medicine and Rehabilitation·Jack B FuEduardo Bruera
Oct 16, 2014·Annals of the New York Academy of Sciences·Frank LeypoldtJosep Dalmau
Nov 14, 2014·Brain : a Journal of Neurology·Jesús PlanagumàJosep Dalmau
Mar 1, 2015·Neurology·Thaís ArmangueJosep Dalmau

❮ Previous
Next ❯

Citations

Jan 7, 2017·Journal of Child Neurology·Sukhvir Wright, Angela Vincent
Jan 23, 2018·The International Journal of Neuroscience·Shuai MiaoBingzhen Cao
Sep 7, 2018·British Journal of Hospital Medicine·Laura MidgleyMichael S Zandi
Sep 22, 2018·The Breast Journal·Benjamin LagunaKimberly M Ray
Aug 21, 2018·Current Opinion in Oncology·Giulia Berzero, Dimitri Psimaras
Dec 24, 2018·Expert Review of Anticancer Therapy·Barouyr BaroudjianUNKNOWN PATIO group
May 8, 2019·Journal of General Internal Medicine·Talya Bordin-WoskSarah F Horman
Sep 18, 2018·Current Neuropharmacology·Hiroshi MitomaChristiane S Hampe
Jul 16, 2019·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Alex Iranzo
Nov 17, 2016·Alzheimer Disease and Associated Disorders·Adalberto Studart NetoRicardo Nitrini
Jan 9, 2020·Journal of Neurology·Matthew BoykoGerald Pfeffer
Apr 11, 2019·Arquivos de neuro-psiquiatria·José Luiz PedrosoOrlando G P Barsottini
Aug 16, 2019·The International Journal of Neuroscience·Yun Yi TanNicola Steele
Nov 28, 2017·Current Treatment Options in Neurology·Malcolm Proudfoot, Alastair Wilkins
Jul 26, 2019·Case Reports in Oncological Medicine·Ruben Manuel Luciano Colunga BiancatelliLuigi Iuliano
Dec 28, 2019·Brain Sciences·Hiroshi MitomaJordi Gandini
Oct 1, 2020·Journal of Clinical Medicine·Lorenzo LorussoMatteo Bertelli
Jun 21, 2016·Journal of Clinical Apheresis
Sep 26, 2017·Cerebellum & Ataxias·Hiroshi MitomaChristiane S Hampe
Apr 8, 2018·Clinical Medicine : Journal of the Royal College of Physicians of London·Mark Ellul, Tom Solomon
Aug 6, 2019·Autoimmune Diseases·Borros M Arneth
Oct 24, 2020·AJNR. American Journal of Neuroradiology·A A MadhavanF E Diehn
Jan 30, 2021·Translational Vision Science & Technology·Jeremy Chung Bo ChiangMaria Markoulli
Feb 1, 2021·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Sarah BasinCécile Cauquil
Mar 26, 2021·Der Nervenarzt·Frederike C OertelFriedemann Paul
Jul 15, 2021·Gynecologic Oncology Reports·Michalis LiontosMeletios-Athanasios Dimopoulos
Sep 15, 2021·Brain and Behavior·Manqiu DingLi Cui
Oct 8, 2021·Seminars in Neurology·Kathryn B HolroydHenrikas Vaitkevicius
Jul 20, 2019·Case Reports in Oncology·Hironori SadamatsuNaoko Sueoka-Aragane
Nov 9, 2021·Frontiers in Neurology·Christopher M BartleyMichael R Wilson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.

Anti-N-Methyl-D-Aspartate Receptor Encephalitis

Anti-N-Methyl-D-Aspartate (NMDA) receptor encephalitis is a form of of brain inflammation due to antibodies against NMDA receptors. Discover the latest research on anti-NMDA receptor encephalitis here.

Ataxia telangiectasia (MDS)

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Ataxias

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on different types of ataxias here.